Aldebaran Capital, LLC Avrobio, Inc. Transaction History

Aldebaran Capital, LLC

  • $110 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$1.15 - $1.48 $71,811 - $92,418
62,445 Added 13.72%
517,431 $662 Million
Q4 2023

Feb 13, 2024
SELL
$1.22 - $1.62 $18,475 - $24,533
-15,144 Reduced 3.22%
454,986 $619 Million
Q3 2023

Nov 13, 2023
BUY
$0.98 - $1.62 $460,727 - $761,610
470,130 New
470,130 $724 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Aldebaran Capital, LLC Portfolio

Follow Aldebaran Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aldebaran Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aldebaran Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email